Alamar Biosciences, Inc. (California) (ALMR)
34.36
+1.90
(+5.85%)
USD |
NASDAQ |
Oct 02, 16:00
34.62
+0.26
(+0.76%)
Pre-Market: 20:00
Alamar Biosciences Gross Profit Margin (Quarterly) : 60.21% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 60.21% |
| March 31, 2026 | 55.53% |
| Date | Value |
|---|---|
| June 30, 2025 | 53.09% |
| March 31, 2025 | 48.80% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| 10X Genomics, Inc. | 74.36% |
| Personalis, Inc. | 21.21% |
| Adaptive Biotechnologies Corp. | 70.15% |
| Champions Oncology, Inc. | 48.48% |
| Medpace Holdings, Inc. | 27.56% |
Gross Profit Margin (Quarterly) Related Metrics
| Profit Margin (Quarterly) | -44.85% |
| Operating Margin (Quarterly) | -45.98% |